• ABOUT IBBL
  • SERVICES
  • RESEARCH
  • GET INVOLVED
  • NEWS
  • CONTACT US
Newsletter Subscription
  • Home
  • |
  • 2016 ANNUAL REPORT
  • |
  • In a Nutshell

In a Nutshell

Looking back into the year 2016, it is undeniable that IBBL has entered a transition phase in its history, becoming a well established, valued and trusted partner in biomedical research. See for yourself in the below dashboard that contains IBBL’s key achievements. Don’t hesitate to click on each image to find out more and tease your curiosity.

Keep on reading our 2016 annual report:

  • Message from the CEO

    Marc Vandelaer unveils IBBL's major developments in 2016, as well as the challenges ahead.

  • Beyond borders

    With 68 projects, IBBL remained a central biobanking infrastructure at the heart of Europe.

  • Dedication to quality

    IBBL's successfully pursued its strategy to provide bioservices of high quality.

  • More than a traditional biobank

    IBBL’s various in-house research projects led to 21 scientific publications.

  • Out of the lab into the real world

    IBBL had use of multi-support resources to make biobanking more approachable and visible.

  • Together for research in Luxembourg

    IBBL worked hand in hand with national partners to advance research in personalised medicine.

IBBL Copyright
  • Annual Reports
  • Scientific Publications
  • Get in Touch
  • NOTICES
We use cookies on our website in order to enhance user navigation and to collect statistical data. By continuing to browse this website you agree to our use of cookies. For more information, you can consult our Cookies Policy.